NCT01350687Unknown不适用
New Phosphore Binders in Prevention of Pulmonary Hypertension
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 40
- 试验地点
- 1
研究概览
简要总结
Pulmonary hypertension is a new complication described in hemodialysis patients. in the last year these patients were treated by calcium carbonate orally to control serum phosphor. Calcium phosphor deposits in pulmonary artery can explain this phenomena. The investigators want to investigate the new phosphor non calcium containing agents in hemodialysis patients and to measure the pulmonary pressure.
详细描述
The investigators will measure pulmonary blood pressure before and after treatment with new phosphor binders, non calcium containing.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Hemodialysis Patients without fistula
排除标准
- •Heart Disease
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Pulmonary Hypertension in Haemodialysis Patients :Frequency and Risk FactorsPulmonary HypertensionNCT03310229Assiut University80
Unknown
4 期
Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.Pulmonary Arterial HypertensionNCT00705588Rabin Medical Center30
已完成
2 期
Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary HypertensionPulmonary HypertensionNCT02216279Montreal Heart Institute45
已完成
2 期
Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® GranulesChronic Kidney DiseaseHyperphosphatemiaNCT02027662Fresenius Medical Care Deutschland GmbH61
已完成
1 期
Phase-I Study of Radiolabeled DFH-12 (PulmoBind) for Molecular Imaging of the Pulmonary CirculationPulmonary DiseasePulmonary HypertensionNCT01539889Montreal Heart Institute20